Teneligliptin hydrobromide hydrate
Catalog No. A21465
Teneligliptin hydrobromide hydrate is a potent chemotype prolylthiazolidine-based DPP-4 inhibitor, which competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM.
| Catalog Num | A21465 |
|---|---|
| M. Wt | 426.58 |
| Formula | C22H30N6OS |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 1572583-29-9 |
| Synonyms | MP-513 hydrobromide hydrate, MP513, MP 513 |
| SMILES | CC1=NN(C2=CC=CC=C2)C(N3CCN([C@]4([H])CN[C@H](C(N5CSCC5)=O)C4)CC3)=C1.CC6=NN(C7=CC=CC=C7)C(N8CCN([C@]9([H])CN[C@H](C(N%10CSCC%10)=O)C9)CC8)=C6.Br.Br.Br.Br.Br.O |
Teneligliptin hydrobromide hydrate is a potent chemotype prolylthiazolidine-based DPP-4 inhibitor, which competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 23.44 mL | 117.21 mL | 234.42 mL |
| 0.5 mM | 4.69 mL | 23.44 mL | 46.88 mL |
| 1 mM | 2.34 mL | 11.72 mL | 23.44 mL |
| 5 mM | 0.47 mL | 2.34 mL | 4.69 mL |
*The above data is based on the productmolecular weight 426.58. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
ADOOQ 产品质量保证
We promise all products to perform as described.